6
Participants
Start Date
October 31, 2010
Primary Completion Date
October 31, 2012
Study Completion Date
October 31, 2012
ranibizumab 2.0mg
Baseline monthly intravitreal injection of ranibizumab 2.0mg for 3 months followed by possible monthly injections up to 9 additional injections
Eye Center of Northern Colorado, Fort Collins
Collaborators (1)
Genentech, Inc.
INDUSTRY
Eye Center of Northern Colorado, P.C.
OTHER